Shattuck Labs (STTK) Assets Average (2020 - 2026)
Shattuck Labs' (STTK) quarterly Assets Average came in at $96.6 million in Q1 2026, up 14.82% year-on-year from $84.1 million in Q1 2025, and up 0.93% on a QoQ basis from $95.7 million in Q4 2025.
Shattuck Labs (STTK) Assets Average (2020 - 2026) Analysis & Trends
Shattuck Labs (STTK) has 7 years of Assets Average data on file, last reported at $96.6 million in Q1 2026.
- On a quarterly basis, Assets Average rose 14.82% year-over-year to $96.6 million in Q1 2026; TTM through Mar 2026 was $96.6 million, a 14.82% increase from a year earlier, with the FY2025 full-year figure at $91.0 million, down 27.35% from the prior year.
- Assets Average for Q1 2026 stood at $96.6 million, up from $95.7 million in the prior quarter.
- Over the last five years, Assets Average for STTK reached as high as $284.5 million in Q1 2022 and fell as low as $70.8 million in Q2 2025.
- Historically, Assets Average has averaged $152.0 million across 5 years, with a median of $142.9 million in 2023.
- Across the five-year window, Assets Average plunged 48.52% in 2025 and increased 14.82% in 2026, its largest moves.
- Year by year, Assets Average stood at $214.1 million in 2022, then plunged by 32.28% to $145.0 million in 2023, then tumbled by 30.08% to $101.4 million in 2024, then declined by 5.63% to $95.7 million in 2025, then rose by 0.93% to $96.6 million in 2026.
- Per Business Quant data, the three most recent Assets Average figures were $96.6 million in Q1 2026, $95.7 million in Q4 2025, and $82.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 65.01 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.37 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 41.64 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.30 Bn |
| 10 | Shattuck Labs | 795.74 Mn | 795.74 Mn | - | 96.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 96.57 Mn |
| Dec 31, 2025 | 95.68 Mn |
| Sep 30, 2025 | 82.35 Mn |
| Jun 30, 2025 | 70.77 Mn |
| Mar 31, 2025 | 84.11 Mn |
| Dec 31, 2024 | 101.38 Mn |
| Sep 30, 2024 | 120.17 Mn |
| Jun 30, 2024 | 137.47 Mn |
| Mar 31, 2024 | 152.95 Mn |
| Dec 31, 2023 | 145.01 Mn |
| Sep 30, 2023 | 142.86 Mn |
| Jun 30, 2023 | 166.47 Mn |
| Mar 31, 2023 | 191.50 Mn |
| Dec 31, 2022 | 214.13 Mn |
| Sep 30, 2022 | 237.14 Mn |
| Jun 30, 2022 | 260.92 Mn |
| Mar 31, 2022 | 284.54 Mn |
| Dec 31, 2021 | 304.58 Mn |
| Sep 30, 2021 | 317.17 Mn |
| Jun 30, 2021 | 330.32 Mn |